Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Histocompatibility

Below is an extended Histocompatibility patents listing. Click here to return to the Histocompatibility main in depth entry.

Patents :

US Patent No.Title
7605166 Methods and compositions for treating rheumatoid arthritis
7608749 Monitoring APP cleavage in transgenic rodents comprising an APP Swedish mutation
7611483 Indicator metrics for infection monitoring
7611693 Mechanism-based targeted pancreatic beta cell imaging and therapy
7611708 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies
7611712 Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide
7611713 Inducing cellular immune responses to hepatitis B virus using peptide compositions
7611839 Methods for diagnosing RCC and other solid tumors
7611854 Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
7611884 Toxoplasma gondii nucleic acid molecules
7612044 Melanoma antigens and their use in diagnostic and therapeutic methods
7608700 Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor
7608693 High affinity human antibodies to human IL-4 receptor
7608686 Human tumor necrosis factor receptor
7605227 Melanoma antigen peptide analogues
7605229 PRO87299 polypeptides
7605233 Tumour necrosis factor binding ligands
7605237 High affinity human antibodies to human IL-4 receptor
7605238 Human CTLA-4 antibodies and their uses
7608274 Therapeutic processes and useful compositions therefor
7608284 Enamel matrix protein composition for treatment of systemic inflammatory response syndrome
7608452 Polynucleotides encoding cytokine receptor zcytor19
7608683 Stress proteins and peptides and methods of use thereof
7608685 Tumor antigen based on products of the tumor suppressor gene WT1
7612110 Utilization of dialkylfumarates
7612170 Co-stimulatory polypeptides
7618622 Treatment of Parkinson's disease and related disorders using postpartum derived cells
7618635 Super-antigen fusion proteins and the use thereof
7618637 Heat shock protein-based vaccines and immunotherapies
7618642 Expression cassettes encoding modified human immunodeficiency virus type 1 subtype C envelope glycoproteins
7618791 Methods of detecting cancer with antibodies to cytokine receptor ZCYTOR19
7618817 Genetically modified human natural killer cell lines
7619001 Utilization of dialkylfumarates
7619057 MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1
7619058 Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same
7619063 Chimeric immunogens
7615611 Human cytokine receptor
7615379 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
7615368 Microarrays of polypeptides
7612172 Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer
7612180 Humanized L243 antibodies
7612191 Polynucleotides encoding interleukin-17 receptor homologue
7615225 Methods for treating a subject having cancer by the administration of a conjugate between a variant staphylococcal entertoxin E superantigen and an antibody that binds to the 5T4 antigen
7615227 Use of CpG oligodeoxynucleotides to induce angiogenesis
7615342 ACTN3 genotype screen for athletic performance
7615349 Melanoma gene signature
7615350 Methods for haplotyping genomic DNA
7615355 Peripheral-type benzodiazepine receptor expression level as an index of organ damage and regeneration
7615359 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
7619071 Antibodies that bind interleukin-17 receptor homologue

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.